Home > Healthcare > Medical Services > Lab Services > U.S. Office-based Labs Market

U.S. Office-based Labs Market Analysis

  • Report ID: GMI8427
  • Published Date: Mar 2024
  • Report Format: PDF

U.S. Office-based Labs Market Analysis

Based on modality, the market is classified into single-specialty labs, multi-specialty labs and hybrid labs. The single speciality labs segment held a market size of 4.7 billion in 2023.

 

  • Single specialty labs focus on a particular area of medicine, enabling healthcare providers to develop specialized expertise in that specific field. This focused approach can lead to quality care, improved patient outcomes, and enhanced diagnostic accuracy.

     

  • Specializing in a single medical field enables office-based labs to streamline operations and allocate resources effectively, tailoring services to meet the unique requirements of patients in that specialty. This streamlined approach enhances efficiency, resulting in reduced wait times, faster delivery of test results, and a higher level of individualized care for patients.

     

  • Moreover, single specialty labs within office-based settings offer cost-efficient solutions, patient-centric approaches, innovation opportunities, and enhanced referral networks.

 

U.S. Office-based Labs Market, By Service (2023)

Based on service, the U.S. office-based labs market is bifurcated into peripheral vascular intervention, endovascular interventions, cardiac services, interventional radiology, venous services, and other services. The peripheral vascular intervention is estimated to account for a market size of USD 6.3 billion by the end of 2032.

 

  • Peripheral vascular interventions play a crucial role in managing the treatment of peripheral arterial disease (PAD), a common condition characterized by narrowed or blocked arteries in the legs.

     

  • Peripheral vascular interventions conducted in OBLs often employ minimally invasive techniques, such as angioplasty, stenting, and atherectomy. These methods result in smaller incisions, minimal trauma to adjacent tissues, and a reduced likelihood of complications.

     

  • Moreover, peripheral vascular interventions in OBLs often involve a multidisciplinary team of healthcare providers, including vascular surgeons, interventional radiologists, cardiologists, and vascular medicine specialists.

     

Based on specialists, the U.S. office-based labs market is segmented into vascular surgeons, interventional, cardiologist, interventional radiologists, and other specialists. The vascular surgeons held a market share of 32.6% in the forecast period.

 

  • Vascular surgeons are highly trained and specialized in diagnosing and treating conditions affecting the arteries, veins, and lymphatic systems. Their expertise encompasses a wide range of vascular procedures, including both open surgical techniques and minimally invasive endovascular interventions.

     

  • Furthermore, vascular surgeons excel in utilizing minimally invasive techniques such as angioplasty, stenting, and atherectomy to treat vascular diseases.

     

  • Moreover, in OBLs, vascular surgeons conduct comprehensive evaluations of patients with vascular conditions, which include performing physical examinations, reviewing medical histories, and interpreting diagnostic tests.

 

U.S. Office-based Labs Market, 2020 – 2032 (USD Billion)

U.S. office-based labs market accounted for USD 11.2 billion revenue in 2023 and is predicted to witness substantial industry progression over the analysis timeline.

 

  • The country has a large population, with an increasing prevalence of targeted diseases such as hypertension, diabetes, hyperlipidemia and rising flexibility for physicians to convert to OBLs which play a crucial in modern healthcare delivery as it expands access, fosters innovation, supports value-based care, enhances efficiency, and improves patient experience.

     

  • For instance, according to the Centers for Disease Control and Prevention (CDC) in 2023 approximately 38.4 million individuals, accounting for 11.6% of the population, were diagnosed with diabetes in U.S.

     

  • Further, U.S. boasts a well-developed healthcare infrastructure with state-of-the-art medical facilities, advanced technologies, and highly skilled healthcare professionals. This infrastructure supports the establishment and operation of OBLs, ensuring high-quality care delivery in the region.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

U.S. office-based labs industry was USD 11.2 billion in revenue in 2023 and is estimated to expand at 7.6% CAGR during 2024-2032 driven by the growing demand by medical service providers due to the increasing prevalence of target diseases.

The peripheral vascular intervention segment is estimated to reach USD 6.3 billion in revenue by 2032 owing to its increasing adoption for managing the treatment of peripheral arterial disease (PAD) across the region.

The single specialty labs segment generated USD 4.7 billion in 2023 and is set to gain significant traction through 2032 as these labs offer cost-efficient solutions, patient-centric approaches, innovation opportunities, and enhanced referral networks.

Some of the leading U.S. office-based labs industry players are Koninklijke Philips N.V, GE Healthcare, Siemens Healthineers AG, Medtronic Plc, Boston Scientific Corporation, Abbott Laboratories, Cardiovascular Systems, Inc., Envision Healthcare, Surgery Care Associates, Inc., Surgery Partners, National Cardiovascular Partners, and TH Medical.

U.S. Office-Based Labs Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 13
  • Tables & Figures: 57
  • Countries covered: 1
  • Pages: 75
 Download Free Sample